8-K: Weave Communications Reports Strong Q3 2025 Results
Quarterly Report
Weave Communications, Inc. announced strong third-quarter 2025 financial results, featuring accelerating revenue growth, non-GAAP profitability, and positive free cash flow.
Summary
- Total revenue reached $61.3 million, marking a 17.1% year-over-year increase compared to $52.4 million in Q3 2024.
- GAAP gross margin improved to 72.3%, up 30 basis points year-over-year, while non-GAAP gross margin rose to 73.0%, up 50 basis points.
- Net cash provided by operating activities was $6.1 million, an increase of $1.6 million year-over-year.
- Free cash flow stood at $5.0 million, up $1.5 million year-over-year.
- GAAP loss from operations was $8.9 million, compared to $6.6 million in Q3 2024.
- Non-GAAP income from operations increased to $1.7 million from $1.4 million in Q3 2024.
- GAAP net loss was $8.7 million, or $0.11 per share, compared to $5.9 million, or $0.08 per share, in Q3 2024.
- Non-GAAP net income was $2.0 million, or $0.03 per share, compared to $2.1 million, or $0.03 per share, in Q3 2024.
- Adjusted EBITDA grew to $2.7 million from $2.2 million in Q3 2024.
- Gross revenue retention was 90%, a decrease from 92% in Q3 2024.
- Net revenue retention was 94%, a decrease from 98% in Q3 2024.
- New payments features, including surcharging and bulk payments, were launched.
- Earned the top rating in the G2 Fall Report for Patient Relationship Management and certified as a Great Place to Work in the U.S. for the seventh consecutive year and in India for the second.
Sentiment
Score: 8
Explanation: The company demonstrated strong revenue growth, improved profitability on a non-GAAP basis, and robust cash flow generation. Strategic product advancements and industry recognition further bolster its position. However, a slight decline in retention rates and increased GAAP net losses warrant monitoring.
Positives
- Accelerating total revenue growth of 17.1% year-over-year to $61.3 million.
- Improved GAAP gross margin to 72.3% (up 30 bps YoY) and Non-GAAP gross margin to 73.0% (up 50 bps YoY).
- Significant increase in net cash provided by operating activities to $6.1 million (up $1.6 million YoY).
- Strong free cash flow generation of $5.0 million (up $1.5 million YoY).
- Non-GAAP income from operations increased to $1.7 million from $1.4 million year-over-year.
- Adjusted EBITDA grew to $2.7 million from $2.2 million year-over-year.
- Successful product roadmap advancements, including new surcharging and bulk payments features.
- Continued industry recognition, earning top rating in G2 Fall Report for Patient Relationship Management.
- Maintained strong company culture, certified as a Great Place to Work for the seventh consecutive year in the U.S. and second in India.
Negatives
- GAAP loss from operations increased to $8.9 million from $6.6 million year-over-year.
- GAAP net loss increased to $8.7 million, or $0.11 per share, from $5.9 million, or $0.08 per share, year-over-year.
- Non-GAAP net income slightly decreased to $2.0 million from $2.1 million year-over-year.
- Gross revenue retention decreased to 90% from 92% year-over-year.
- Net revenue retention decreased to 94% from 98% year-over-year.
Risks
- Ability to successfully integrate the acquisition of TrueLark and achieve expected benefits from the acquisition.
- Ability to attract new customers, retain existing customers, and increase customer use of the platform.
- Ability to manage growth effectively.
- Impact of unfavorable economic conditions and macroeconomic uncertainties on the company.
- Ability to maintain and enhance brand and increase market awareness of the company, platform, and products.
- Customer adoption rates of the platform, products, and enhancements.
- Customer acquisition costs and effectiveness of sales and marketing strategies.
- Ability to achieve profitability in any future period.
- Competitive pressures within the market.
- Ability to enhance the platform and products to meet evolving market demands.
- Potential interruptions in service.
- General risks described in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.
Future Outlook
The company expects full-year 2025 total revenue to be between $238.0 million and $239.0 million, and non-GAAP income from operations to range from $3.3 million to $4.3 million. For the fourth quarter of 2025, total revenue is projected to be $62.4 million to $63.4 million, with non-GAAP income from operations between $1.5 million and $2.5 million.
Management Comments
- "We delivered another strong quarter, marked by accelerating revenue growth, non-GAAP profitability, and free cash flow as well as significant advancements across our product roadmap."
- "The SMB healthcare market is evolving rapidly, with technology playing a greater role in how practices attract, engage, and retain patients."
- "Weave is uniquely positioned to lead in this next phase of transformation. Our scale, brand, and deep expertise in SMB healthcare give us an advantage."
Industry Context
The SMB healthcare market is rapidly evolving, with technology becoming increasingly crucial for patient attraction, engagement, and retention. Weave positions itself as a leader in this transformation due to its scale, brand, and deep expertise in the sector, offering AI-powered patient engagement and payment solutions.
Comparison to Industry Standards
- Weave's top rating in the G2 Fall Report for Patient Relationship Management indicates strong customer satisfaction and competitive standing within its specific vertical SaaS niche, suggesting it outperforms or is highly regarded compared to other patient relationship management software providers.
- The certification as a Great Place to Work in the U.S. (7th year) and India (2nd year) suggests a strong internal culture and employee satisfaction, which can be a competitive advantage in attracting and retaining talent compared to other tech companies in the SaaS or healthcare technology sectors.
- The company's focus on AI-powered solutions and new payment features like surcharging and bulk payments addresses evolving needs in the healthcare SMB market, potentially positioning it ahead of competitors that may not offer similar integrated solutions for managing costs and streamlining payment processes.
Stakeholder Impact
- Shareholders: Positive impact due to accelerating revenue growth, non-GAAP profitability, and strong free cash flow, potentially leading to increased shareholder value. However, increased GAAP losses and slightly lower retention rates could be a concern.
- Customers (SMB healthcare practices): Positive impact from new payments features (surcharging, bulk payments) and continued high satisfaction as evidenced by G2 ratings, enhancing their ability to manage costs and streamline operations.
- Employees: Positive impact from the company being certified as a Great Place to Work in the U.S. and India, indicating a supportive work environment.
- Creditors/Suppliers: Stable or positive impact due to improved cash flow from operations and free cash flow, indicating better financial health and ability to meet obligations.
Next Steps
- Host a conference call and webcast for analysts and investors on October 30, 2025, at 4:30 p.m. EST.
- Continue to integrate the acquisition of TrueLark.
- Further enhance the platform and products, including AI-powered solutions.
- Focus on attracting new customers and retaining existing ones.
Key Dates
| Date | Description |
|---|---|
| May 2025 | Acquisition of Vidurama, Inc. (d.b.a. TrueLark) |
| August 7, 2025 | Filing date of Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 |
| September 30, 2025 | End of the third fiscal quarter |
| October 30, 2025 | Date of earliest event reported (8-K filing date), Press Release Announcing Financial Results, Conference call and webcast for analysts and investors |
Recommendation
buyThe company is demonstrating accelerating revenue growth, strong non-GAAP profitability, and significant free cash flow generation, indicating a healthy operational trajectory. While GAAP losses increased, the non-GAAP metrics and cash flow performance are robust. The strategic product advancements and strong market positioning in the evolving SMB healthcare sector suggest continued growth potential. The positive full-year outlook further supports a favorable investment view.
Keywords
Weave Communications, WEAV, SaaS, healthcare technology, patient engagement, payment solutions, SMB healthcare, financial results, Q3 2025, earnings, software, AI-powered, vertical SaaS
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.